What We Do - Advanced Oxygen Therapy Inc.
AOTI is dedicated to providing Advanced Wound Care products that utilize our patented non-invasive Topical Wound Oxygen (TWO 2) therapy. Our innovative products can help close all wound types, and are particularly effective in chronic (diabetic, pressure, and venous ulcers) and acute (post-surgical, cosmetic, and burn) wounds.
Description
More Products & Services
Products & Services
Regulatory - Advanced Oxygen Therapy Inc.
Advanced Oxygen Therapy
AOTI is an FDA QSR and ISO 13485:2012 compliant company and all our products are CE marked and FDA Cleared. Advanced Oxygen Therapy Inc. is an ACHC Accredited DMEPOS provider. The following links allow you to download our current regulatory certificates:
MB1001 C Healing Chronic Wounds Completely
Advanced Oxygen Therapy
Single-use Sacral Systems - Advanced Oxygen Therapy Inc.
Advanced Oxygen Therapy
AOTI offers a single-use Topical Wound Oxygen (TWO 2)Sacral system utilizing targeted therapy for all types of wounds on the torso, such as pressure ulcers, and can easily be applied at any care site, including hospitals, LTACs, Wound Care Clinics, SNFs, nursing homes, and to the patients' homes.
Single-use Extremity Systems - Advanced Oxygen Therapy Inc.
Advanced Oxygen Therapy
AOTI offers a wide range of single-use Topical Wound Oxygen (TWO 2) extremity chambers to allow our therapy to be applied effortlessly while meeting the needs of our customers in such varied care sites as hospitals, LTACs, Wound Care Clinics, SNFs, nursing homes, and patient homes.
AOTI COVID-19 Message
Advanced Oxygen Therapy
How TWO2 can support you and your patients during this time of need at home:
People
Description
AOTI is dedicated to providing Advanced Wound Care products that utilize our patented non-invasive Topical Wound Oxygen (TWO 2) therapy. Our innovative products can help close all wound types, and are particularly effective in chronic (diabetic, pressure, and venous ulcers) and acute (post-surgical, cosmetic, and burn) wounds.
Share
Recent Chats
Share via email
Future: handle WhatsApp here
Future: handle LinkedIn here
Future: handle Twitter here
SUBMENU HERE
Share via Chat
Copy Link